Skip to main content
INSM
NASDAQ Life Sciences

Insmed Q3 Revenue Hits $524.4M as BRINSUPRI Grows 29% Sequentially, Guidance Raised

Tom Rudovsky · Reported by PR Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$98.77
Mkt Cap
$21.179B
52W Low
$90.39
52W High
$212.75
52W Position info
9.3% above low
Off High info
54% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

INSM is trading near its 52-week low of $90.39 (9.3% above the low).

Summary

Insmed posted Q3 2026 total revenue of $524.4 million, up 268% from $142.3 million a year ago, with BRINSUPRI contributing $400.1 million — 29% growth over Q2's launch-driven base. ARIKAYCE added $124.4 million, up 9% year-over-year on international strength. The company raised the low end of full-year BRINSUPRI guidance to $1.35-1.4 billion (from $1.25-1.4 billion) and ARIKAYCE to $460-470 million (from $450-470 million). Net loss narrowed to $100.3 million, or $0.46 per share, from $370.0 million a year earlier, though R&D ($270.0 million) and SG&A ($253.0 million) both climbed on TPIP development and BRINSUPRI commercialization spend. This follows the Q2 blowout that sent shares up 33% in August; the sequential BRINSUPRI growth and guidance raise confirm the launch curve is holding. The FDA's Priority Review of the ARIKAYCE sNDA carries a PDUFA target of January 28, 2027, and Japan PMDA submission of ENCORE data is planned for Q4 2026.

At the time of this announcement, INSM was trading at $98.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $21.2B. The 52-week trading range was $90.39 to $212.75. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

INSM - Latest Insights

INSM
Oct 30, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $110.91
Real-time Price: $121.16 info
Change: +$10.25 (+9%) info
Market Cap: $26.58B info
INSM
Oct 29, 2026, 12:51 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $110.63
Real-time Price: $121.16 info
Change: +$10.53 (+10%) info
Market Cap: $26.58B info
INSM
Oct 29, 2026, 7:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $98.77
Real-time Price: $121.16 info
Change: +$22.39 (+23%) info
Market Cap: $26.58B info
INSM
Oct 15, 2026, 8:54 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $96.60
Real-time Price: $121.16 info
Change: +$24.56 (+25%) info
Market Cap: $26.58B info
INSM
Oct 05, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $112.63
Real-time Price: $121.16 info
Change: +$8.53 (+8%) info
Market Cap: $26.58B info